News FluoGuide A/S

Equities

FLUO

DK0061123312

Market Closed - Nasdaq Stockholm Other stock markets 11:29:40 2024-04-25 am EDT			5-day change	1st Jan Change
45.5 ^SEK	-5.60%		+1.79%	-25.65%

Mar. 20	FluoGuide A/S Approves Board Changes	CI
Mar. 12	FluoGuide A/S Enters Collaboration Within Robot Assisted Head and Neck Cancer Surgery with Intuitive Surgical, Inc	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

FluoGuide A/S Approves Board Changes	Mar. 20	CI
Minutes from Annual General Meeting in FluoGuide A/S	Mar. 20	AQ
Chief Financial Officer (CFO) Ole Larsen buys shares	Mar. 13	AQ
FluoGuide enters collaboration within robot assisted head and neck cancer surgery with Intuitive Surgical, a world leading robotic-assisted surgery company	Mar. 12	AQ
FluoGuide A/S Enters Collaboration Within Robot Assisted Head and Neck Cancer Surgery with Intuitive Surgical, Inc	Mar. 12	CI
Notice of Annual General Meeting in FluoGuide A/S	Mar. 01	AQ
Fluoguide Q4 2023 - Bright prospects	Feb. 28	AQ
FluoGuide A/S publishes year-end and annual report for the fiscal year 2023	Feb. 28	AQ
FluoGuide A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
FluoGuide A/S issues warrants to CFO	Feb. 23	AQ
FluoGuide A/S Provides Strategic Update and Outlines Development Plans Towards Commercialization of FG001	Jan. 08	CI
FluoGuide provides strategic update and outlines development plans towards commercialization of FG001	Jan. 08	AQ
FluoGuide raises SEK 12 million through exercise of warrants	Dec. 11	AQ
Chief Development Officer (CDO) Grethe Nørskov Rasmussen sells shares	Dec. 09	AQ
FluoGuide raises SEK 12 million through exercise of warrants	Dec. 08	AQ
Fluoguide Q3 2023 - Spoilt for choice	Nov. 29	AQ
FluoGuide A/S publishes interim report for the period January – September 2023	Nov. 29	AQ
FluoGuide A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
FluoGuide announces FG001 meets primary endpoint in phase llb trial in aggressive brain cancer	Nov. 13	AQ
FluoGuide A/S Announces FG001 Meets Primary Endpoint in Phase LLB Trial in Aggressive Brain Cancer	Nov. 13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News FluoGuide A/S

Equities

FLUO

DK0061123312

Summary

Filters